Butterfly Network (BFLY) Consolidated Net Income (2020 - 2026)
Butterfly Network (BFLY) reported Consolidated Net Income of -$12.7 million for Q1 2026, up 9.24% on a YoY basis from -$11.6 million in Q1 2025, and up 17.05% sequentially from -$15.3 million in Q4 2025.
Butterfly Network (BFLY) Consolidated Net Income (2020 - 2026) Analysis & Trends
Butterfly Network (BFLY) has 7 years of Consolidated Net Income data on file, last reported at -$12.7 million in Q1 2026.
- For the quarter ending Q1 2026, Consolidated Net Income rose 9.24% year-over-year to -$12.7 million; the trailing twelve-month figure through Mar 2026 stood at -$75.8 million (down 17.1% YoY), and the FY2025 full-year result was -$77.1 million, down 6.29% from the prior year.
- Consolidated Net Income advanced to -$12.7 million in Q1 2026, from -$15.3 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of -$12.7 million in Q1 2026 to a low of -$54.7 million in Q3 2022.
- A 5-year average of -$27.3 million and a median of -$27.4 million in 2023 frame the typical range for Consolidated Net Income.
- Across the five-year window, Consolidated Net Income sank 6345.94% in 2022 and surged 58.97% in 2024, its largest moves.
- Tracing BFLY's Consolidated Net Income over 5 years: stood at -$33.7 million in 2022, then slumped by 30.91% to -$44.1 million in 2023, then surged by 58.97% to -$18.1 million in 2024, then rose by 15.58% to -$15.3 million in 2025, then increased by 17.05% to -$12.7 million in 2026.
- Business Quant data shows BFLY's Consolidated Net Income at -$12.7 million in Q1 2026, -$15.3 million in Q4 2025, and -$34.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Butterfly Network | 1.70 Bn | 1.56 Bn | 18.29 Mn | -12.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.68 Mn |
| Dec 31, 2025 | -15.28 Mn |
| Sep 30, 2025 | -33.97 Mn |
| Jun 30, 2025 | -13.83 Mn |
| Mar 31, 2025 | -13.97 Mn |
| Dec 31, 2024 | -18.10 Mn |
| Sep 30, 2024 | -16.92 Mn |
| Jun 30, 2024 | -15.71 Mn |
| Mar 31, 2024 | -21.76 Mn |
| Dec 31, 2023 | -44.12 Mn |
| Sep 30, 2023 | -27.37 Mn |
| Jun 30, 2023 | -28.67 Mn |
| Mar 31, 2023 | -33.54 Mn |
| Dec 31, 2022 | -33.70 Mn |
| Sep 30, 2022 | -54.74 Mn |
| Jun 30, 2022 | -35.80 Mn |
| Mar 31, 2022 | -44.48 Mn |
| Dec 31, 2021 | -15.63 Mn |
| Sep 30, 2021 | -13.56 Mn |
| Jun 30, 2021 | -2.94 Mn |